These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8717507)

  • 21. Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition.
    Erickson HA; Jund MD; Pennell CA
    Protein Eng Des Sel; 2006 Jan; 19(1):37-45. PubMed ID: 16243897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies in the therapy of colon cancer.
    Welt S; Ritter G
    Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of immunotoxins for the therapy of cancer, AIDS, and immune dysfunctions.
    Vitetta ES
    Princess Takamatsu Symp; 1988; 19():333-40. PubMed ID: 3077626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reasonable design of antibody mimetics for targeting glioma and small cell lung cancer.
    Jiang T; Zhang L; Wang J; Li X
    Eur J Cancer Prev; 2009 Nov; 18(6):431-5. PubMed ID: 19741543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunotoxins].
    Gedikoğlu S
    Mikrobiyol Bul; 1990 Jan; 24(1):79-87. PubMed ID: 2283968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
    Shapira S; Lisiansky V; Arber N; Kraus S
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent small cell lung cancer: update.
    Glisson BS
    Semin Oncol; 2003 Feb; 30(1):72-8. PubMed ID: 12635091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer therapy by using bispecific antibody].
    Azuma A; Niitani H; Okumura K
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1535-42. PubMed ID: 1872618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
    Chiron MF
    Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotoxin treatment of cancer.
    Pastan I; Hassan R; FitzGerald DJ; Kreitman RJ
    Annu Rev Med; 2007; 58():221-37. PubMed ID: 17059365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors.
    Bjorn MJ; Groetsema G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6639-45. PubMed ID: 3499979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic engineering of immunotoxins.
    Chandler JC; Frankel AE; Tagge EP
    Semin Pediatr Surg; 1996 Aug; 5(3):206-11. PubMed ID: 8858768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted delivery of toxins and enzymes by antibodies and growth factors.
    Houston LL
    Curr Opin Biotechnol; 1993 Dec; 4(6):739-44. PubMed ID: 7764474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotoxicity of immunotoxins.
    Ilercil O; Laske DW; Walbridge S; Muaszko K; Oldfield EH; Youle RJ
    Mol Chem Neuropathol; 1994; 21(2-3):379-86. PubMed ID: 8086044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective elimination of autoreactive lymphocytes with immunotoxins.
    Krolick KA
    Clin Immunol Immunopathol; 1989 Mar; 50(3):273-82. PubMed ID: 2645071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotoxins: status and prospects.
    Spooner RA; Lord JM
    Trends Biotechnol; 1990 Jul; 8(7):189-93. PubMed ID: 1366624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage-targeted therapy: CD64-based immunotoxins for treatment of chronic inflammatory diseases.
    Hristodorov D; Mladenov R; Huhn M; Barth S; Thepen T
    Toxins (Basel); 2012 Sep; 4(9):676-94. PubMed ID: 23105975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hybrid recombinant proteins: structure, properties and use].
    Urakov NN; Veriasova GV; Sokov BN; Kavyzina LI; Sergeeva NL
    Vestn Ross Akad Med Nauk; 1994; (4):46-51. PubMed ID: 7516767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-Based Immunotoxins for Colorectal Cancer Therapy.
    Sanz L; Ibáñez-Pérez R; Guerrero-Ochoa P; Lacadena J; Anel A
    Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.